Phase II Evaluation of Weekly Docetaxel in Combination With Weekly Carboplatin in the Treatment of Recurrent Epithelial Ovarian Carcinoma
Phase II Evaluation of Weekly Docetaxel in Combination With Weekly Carboplatin in the Treatment of Recurrent Epithelial Ovarian Carcinoma
The purpose of this study is to determine the safety and efficacy of this regimen in women with ovarian or peritoneal cancer
Inclusion Criteria:
Exclusion Criteria: